SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600132-16-000119
Filing Date
2016-11-08
Accepted
2016-11-08 06:38:31
Documents
57
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q blph-093016x10q.htm 10-Q 751282
2 EXHIBIT 31.1 q31610-qexhibit311.htm EX-31.1 9910
3 EXHIBIT 31.2 q31610-qexhibit312.htm EX-31.2 9928
4 EXHIBIT 32 q31610-qexhibit32.htm EX-32 10804
  Complete submission text file 0001600132-16-000119.txt   4075270

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blph-20160930.xml EX-101.INS 690837
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blph-20160930.xsd EX-101.SCH 40674
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blph-20160930_cal.xml EX-101.CAL 48959
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blph-20160930_def.xml EX-101.DEF 179869
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blph-20160930_lab.xml EX-101.LAB 510354
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blph-20160930_pre.xml EX-101.PRE 284339
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36845 | Film No.: 161979910
SIC: 2834 Pharmaceutical Preparations